# Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)

> clinical trial · VERIFIED · 2026-07-06

Status: RECRUITING · Sponsor: Merck Sharp & Dohme LLC · Condition: Esophageal Squamous Cell Carcinoma

- Company: Merck Sharp & Dohme LLC
- Sector: Esophageal Squamous Cell Carcinoma
- Primary source: https://clinicaltrials.gov/study/NCT06780111

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.